Fuyuan Pharmaceutical announced that Fuyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, obtained “erythromycin Eye Ointment” and “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. The drug marketing license holder was changed from Xi'an Kanghua Pharmaceutical Co., Ltd. to Fuyuan Pharmaceutical Co., Ltd. This drug is mainly used for trachoma, conjunctivitis, blepharitis and external eye infections.

Zhitongcaijing · 01/07 08:33
Fuyuan Pharmaceutical announced that Fuyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, obtained “erythromycin Eye Ointment” and “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. The drug marketing license holder was changed from Xi'an Kanghua Pharmaceutical Co., Ltd. to Fuyuan Pharmaceutical Co., Ltd. This drug is mainly used for trachoma, conjunctivitis, blepharitis and external eye infections.